Medicus Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	8.66	4.16	1.72	0.27	0.08
Cash & Short-Term Investments	8.66	4.16	1.72	0.27	0.08
Cash Growth	63.25%	142.21%	542.38%	240.90%	-
Prepaid Expenses	0.73	1.21	0.17	0.02	-
Total Current Assets	9.78	5.38	1.89	0.28	0.08
Property, Plant & Equipment	0.2	0.27	-	-	-
Total Assets	9.98	5.65	1.89	0.28	0.08
Accounts Payable	2.03	1.28	0.21	0.1	0.16
Accrued Expenses	1.7	0.76	0.4	-	-
Short-Term Debt	6.79	0.14	0.17	1.53	0.67
Current Portion of Leases	0.14	0.12	-	-	-
Other Current Liabilities	-	-	-	10.85	9.75
Total Current Liabilities	10.66	2.31	0.78	12.48	10.58
Long-Term Leases	0.1	0.21	-	-	-
Total Liabilities	10.78	2.51	0.78	12.48	10.58
Common Stock	48.48	30.52	18.76	0.19	0.19
Additional Paid-In Capital	6.45	1.52	0.1	-	-
Retained Earnings	-56.16	-28.9	-17.75	-12.39	-10.7
Shareholders' Equity	-0.8	3.13	1.11	-12.2	-10.51
Total Liabilities & Equity	9.98	5.65	1.89	0.28	0.08
Total Debt	7.05	0.46	0.17	1.53	0.67
Net Cash (Debt)	1.61	3.7	1.55	-1.26	-0.59
Net Cash Growth	-67.51%	138.16%	-	-	-
Net Cash Per Share	0.10	0.38	0.45	-0.67	-0.18
Filing Date Shares Outstanding	22.03	11.82	8.08	6.43	3.22
Total Common Shares Outstanding	20.97	11.82	8.08	6.43	3.22
Working Capital	-0.88	3.07	1.11	-12.2	-10.51
Book Value Per Share	-0.04	0.27	0.14	-1.90	-3.27
Tangible Book Value	-0.91	3.13	1.11	-12.2	-10.51
Tangible Book Value Per Share	-0.04	0.27	0.14	-1.90	-3.27

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q